[1]
Subroto, D.R.T. and Triguna, I.P.B. 2025. A Severe Hyponatremia in a Renal Cell Carcinoma Patient Treated with Pembrolizumab: Possible Immune Checkpoint Inhibitor–Induced Secondary Adrenal Insufficiency. Indonesian Journal of Biomedicine and Clinical Sciences. 57, 3 (Sep. 2025), 46-47. DOI:https://doi.org/10.22146/inajbcs.v57i3.Supplement.24201.